BackDV Biomed , Ltd. Overview
DV Biomed Co., Ltd.

DV Biomed , Ltd. Return on Equity

DV Biomed , Ltd. (6539.TWO) has a ROE of 13.94%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

13.94%

Return on Equity

13.94%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

DV Biomed , Ltd. (6539.TWO) FAQ

DV Biomed , Ltd. (6539.TWO) currently reports a ROE of 13.94%. That is above the sector sector average of 11.3%. Use the charts on this page to explore DV Biomed , Ltd.'s ROE history and peer comparisons.

DV Biomed , Ltd.'s ROE of 13.94% is higher than the its sector sector average of 11.3%. That is roughly 23.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but DV Biomed , Ltd.'s current 13.94% should be judged against industry norms (sector average: 11.3%) and against 6539.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 13.94%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.3%. From there, open related valuation or income-statement pages for DV Biomed , Ltd., and consider following 6539.TWO for alerts when major investors trade the stock.